Selected research
Industry Research
Glipizide Industry Research Report 2026
Market perspective
The global Glipizide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glipizide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glipizide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glipizide include CCPC, TEVA, Lukang Pharma, United Laboratories, Jumpcan, Pfizer, PIDI, Disha Pharma and Jingfeng Zhiyao, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glipizide market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glipizide Market by Company
CCPC
TEVA
Lukang Pharma
United Laboratories
Jumpcan
Pfizer
PIDI
Disha Pharma
Jingfeng Zhiyao
Yashica Pharma
Apotex
Glipizide Segment by Type
Glipizide Tablets
Glipizide Sustained Release Tablets
Others
Glipizide Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Glipizide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glipizide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glipizide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glipizide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glipizide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glipizide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glipizide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glipizide Tablets
- Glipizide Sustained Release Tablets
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- CCPC
- TEVA
- Lukang Pharma
- United Laboratories
- Jumpcan
- Pfizer
- PIDI
- Disha Pharma
- Jingfeng Zhiyao
- Yashica Pharma
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glipizide Market Size (2021-2032)
- 2.2.2 Global Glipizide Sales (2021-2032)
- 2.2.3 Global Glipizide Market Average Price (2021-2032)
- 2.3 Glipizide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glipizide Tablets
- 2.3.3 Glipizide Sustained Release Tablets
- 2.3.4 Others
- 2.4 Glipizide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glipizide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glipizide Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Glipizide Revenue of Manufacturers (2021-2026)
- 3.4 Global Glipizide Average Price by Manufacturers (2021-2026)
- 3.5 Global Glipizide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glipizide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glipizide, Product Type & Application
- 3.8 Global Manufacturers of Glipizide, Established Date
- 3.9 Global Glipizide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CCPC
- 4.1.1 CCPC Company Information
- 4.1.2 CCPC Business Overview
- 4.1.3 CCPC Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CCPC Glipizide Product Portfolio
- 4.1.5 CCPC Recent Developments
- 4.2 TEVA
- 4.2.1 TEVA Company Information
- 4.2.2 TEVA Business Overview
- 4.2.3 TEVA Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 TEVA Glipizide Product Portfolio
- 4.2.5 TEVA Recent Developments
- 4.3 Lukang Pharma
- 4.3.1 Lukang Pharma Company Information
- 4.3.2 Lukang Pharma Business Overview
- 4.3.3 Lukang Pharma Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lukang Pharma Glipizide Product Portfolio
- 4.3.5 Lukang Pharma Recent Developments
- 4.4 United Laboratories
- 4.4.1 United Laboratories Company Information
- 4.4.2 United Laboratories Business Overview
- 4.4.3 United Laboratories Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 United Laboratories Glipizide Product Portfolio
- 4.4.5 United Laboratories Recent Developments
- 4.5 Jumpcan
- 4.5.1 Jumpcan Company Information
- 4.5.2 Jumpcan Business Overview
- 4.5.3 Jumpcan Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jumpcan Glipizide Product Portfolio
- 4.5.5 Jumpcan Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Glipizide Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 PIDI
- 4.7.1 PIDI Company Information
- 4.7.2 PIDI Business Overview
- 4.7.3 PIDI Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PIDI Glipizide Product Portfolio
- 4.7.5 PIDI Recent Developments
- 4.8 Disha Pharma
- 4.8.1 Disha Pharma Company Information
- 4.8.2 Disha Pharma Business Overview
- 4.8.3 Disha Pharma Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Disha Pharma Glipizide Product Portfolio
- 4.8.5 Disha Pharma Recent Developments
- 4.9 Jingfeng Zhiyao
- 4.9.1 Jingfeng Zhiyao Company Information
- 4.9.2 Jingfeng Zhiyao Business Overview
- 4.9.3 Jingfeng Zhiyao Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jingfeng Zhiyao Glipizide Product Portfolio
- 4.9.5 Jingfeng Zhiyao Recent Developments
- 4.10 Yashica Pharma
- 4.10.1 Yashica Pharma Company Information
- 4.10.2 Yashica Pharma Business Overview
- 4.10.3 Yashica Pharma Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Yashica Pharma Glipizide Product Portfolio
- 4.10.5 Yashica Pharma Recent Developments
- 4.11 Apotex
- 4.11.1 Apotex Company Information
- 4.11.2 Apotex Business Overview
- 4.11.3 Apotex Glipizide Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Apotex Glipizide Product Portfolio
- 4.11.5 Apotex Recent Developments
5 Global Glipizide Market Scenario by Region
- 5.1 Global Glipizide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glipizide Sales by Region: 2021-2032
- 5.2.1 Global Glipizide Sales by Region: 2021-2026
- 5.2.2 Global Glipizide Sales by Region: 2027-2032
- 5.3 Global Glipizide Revenue by Region: 2021-2032
- 5.3.1 Global Glipizide Revenue by Region: 2021-2026
- 5.3.2 Global Glipizide Revenue by Region: 2027-2032
- 5.4 North America Glipizide Market Facts & Figures by Country
- 5.4.1 North America Glipizide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glipizide Sales by Country (2021-2032)
- 5.4.3 North America Glipizide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glipizide Market Facts & Figures by Country
- 5.5.1 Europe Glipizide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glipizide Sales by Country (2021-2032)
- 5.5.3 Europe Glipizide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glipizide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glipizide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glipizide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glipizide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glipizide Market Facts & Figures by Country
- 5.7.1 South America Glipizide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glipizide Sales by Country (2021-2032)
- 5.7.3 South America Glipizide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Glipizide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glipizide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glipizide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glipizide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glipizide Sales by Type (2021-2032)
- 6.1.1 Global Glipizide Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Glipizide Sales Market Share by Type (2021-2032)
- 6.2 Global Glipizide Revenue by Type (2021-2032)
- 6.2.1 Global Glipizide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glipizide Revenue Market Share by Type (2021-2032)
- 6.3 Global Glipizide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glipizide Sales by Application (2021-2032)
- 7.1.1 Global Glipizide Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Glipizide Sales Market Share by Application (2021-2032)
- 7.2 Global Glipizide Revenue by Application (2021-2032)
- 7.2.1 Global Glipizide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glipizide Revenue Market Share by Application (2021-2032)
- 7.3 Global Glipizide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glipizide Value Chain Analysis
- 8.1.1 Glipizide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glipizide Production Mode & Process
- 8.2 Glipizide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glipizide Distributors
- 8.2.3 Glipizide Customers
9 Global Glipizide Analyzing Market Dynamics
- 9.1 Glipizide Industry Trends
- 9.2 Glipizide Industry Drivers
- 9.3 Glipizide Industry Opportunities and Challenges
- 9.4 Glipizide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst